BioCentury
ARTICLE | Clinical News

Crinobulin: Phase Ia data

June 8, 2009 7:00 AM UTC

Data from a Phase Ia trial in 11 patients showed that 13-30 mg/m 2 IV EPC2407 produced stable disease in 2 patients with hepatocellular carcinoma. Both patients received 18 mg/m 2 IV EPC2407. The MTD ...